by David Maiorana | May 3, 2018 | Federal Circuit Appeal, PTAB News
By: Dave Maiorana On April 24, 2018, the U.S. Supreme Court issued its decision in SAS Institute Inc. v. Iancu, where the Court held that the Patent Trial and Appeal Board (PTAB) must issue a final written decision as to any patent claim challenged by an IPR...
by S. Christian Platt | Apr 30, 2018 | PTAB News
By: Tom Koglman, Rich Graham, and S. Christian Platt On April 18, 2018, the Director of the USPTO Andrei Iancu informed the U.S. Senate Judiciary Committee that he aims to propose changes to America Invents Act reviews by this summer 2018. The Director told the...
by Matthew Johnson | Apr 26, 2018 | PTAB News
By: Matt Johnson, Greg Castanias, Gasper LaRosa, and Rich Graham Rumors of the PTAB’s demise were greatly exaggerated, it turns out. In a 7-2 decision, the Supreme Court held on Tuesday that Inter Partes Reviews (IPRs) violate neither Article III nor the Seventh...
by Greg Castanias | Apr 25, 2018 | PTAB News
By: Greg Castanias and Rich Graham AS Institute In a win for Jones Day client SAS Institute, a cross-office, cross-practice Jones Day team—Greg Castanias, John Marlott, and Dave Cochran—convinced the U.S. Supreme Court that the PTAB’s practice of instituting inter...
by Mike Lavine | Apr 4, 2018 | Final Written Decisions, PTAB News
By: Mike Lavine On March 21, 2018 the PTAB issued a press release announcing that two decisions denying review under 35 U.S.C. § 325(d) are designated as informative: Kayak Software Corp.v. International Business Machines Corp., CBM2016-00075, Paper 16 (PTAB Dec. 15,...
by Joe Sauer | Feb 27, 2018 | PTAB News, PTAB Trial Basics
By: Tom Koglman and Joe Sauer In a case of first impression, the PTAB recently decided that the doctrine of tribal sovereign immunity does not apply to inter partes review proceedings. See Mylan Pharmaceuticals Inc. v. Saint Regis Mohawk Tribe, IPR2016-01127;...
